Metabolomic Analyses of Plasma Reveals New Insights into Asphyxia and Resuscitation in Pigs by Solberg, Rønnaug et al.
Metabolomic Analyses of Plasma Reveals New Insights
into Asphyxia and Resuscitation in Pigs
Rønnaug Solberg
1,2, David Enot
3, Hans-Peter Deigner
3, Therese Koal
3, Sabine Scholl-Bu ¨rgi
4, Ola D.
Saugstad
1, Matthias Keller
5*
1Department of Pediatric Research, Oslo University Hospital, Rikshospitalet, University of Oslo, Norway, 2Department for Surgical Research, Oslo University Hospital,
Rikshospitalet, University of Oslo, Norway, 3BIOCRATES Life Sciences AG, Innsbruck, Austria, 4Innsbruck Medical University, Department of Pediatrics IV, Division of
Neuropediatrics and Inherited Metabolic Disorders, Innsbruck, Austria, 5Department of Pediatrics I, Neonatology, University Essen, Essen, Germany
Abstract
Background: Currently, a limited range of biochemical tests for hypoxia are in clinical use. Early diagnostic and functional
biomarkers that mirror cellular metabolism and recovery during resuscitation are lacking. We hypothesized that the
quantification of metabolites after hypoxia and resuscitation would enable the detection of markers of hypoxia as well as
markers enabling the monitoring and evaluation of resuscitation strategies.
Methods and Findings: Hypoxemia of different durations was induced in newborn piglets before randomization for
resuscitation with 21% or 100% oxygen for 15 min or prolonged hyperoxia. Metabolites were measured in plasma taken
before and after hypoxia as well as after resuscitation. Lactate, pH and base deficit did not correlate with the duration of
hypoxia. In contrast to these, we detected the ratios of alanine to branched chained amino acids (Ala/BCAA; R
2.adj=0.58, q-
value,0.001) and of glycine to BCAA (Gly/BCAA; R
2.adj=0.45, q-value,0.005), which were highly correlated with the
duration of hypoxia. Combinations of metabolites and ratios increased the correlation to R
2adjust=0.92. Reoxygenation
with 100% oxygen delayed cellular metabolic recovery. Reoxygenation with different concentrations of oxygen reduced
lactate levels to a similar extent. In contrast, metabolites of the Krebs cycle (which is directly linked to mitochondrial
function) including alpha keto-glutarate, succinate and fumarate were significantly reduced at different rates depending on
the resuscitation, showing a delay in recovery in the 100% reoxygenation groups. Additional metabolites showing different
responses to reoxygenation include oxysterols and acylcarnitines (n=8–11, q,0.001).
Conclusions: This study provides a novel strategy and set of biomarkers. It provides biochemical in vivo data that
resuscitation with 100% oxygen delays cellular recovery. In addition, the oxysterol increase raises concerns about the safety
of 100% O2 resuscitation. Our biomarkers can be used in a broad clinical setting for evaluation or the prediction of damage
in conditions associated with low tissue oxygenation in both infancy and adulthood. These findings have to be validated in
human trials.
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Introduction
Approximately 5–10% of newborns require some kind of
assistance to start breathing after birth [1], and approximately 1%
need more extensive interventions. Recent research has shown
that the use of extra oxygen for newborn resuscitation negatively
influences both morbidity and mortality [2–7] However, it is still
widely used, and the pathophysiology is not yet fully understood.
Furthermore, perinatal asphyxia is a worldwide problem and a
leading cause of morbidity as well as mortality in the neonatal
period, causing around one million deaths each year [8]. Despite
declining incidence of hypoxic-ischemic encephalopathy (HIE)
following asphyxia [9], still approximately 1/1000 newborns, and
in developing countries even 5–10/1000, suffer from moderate
or severe HIE, [10] with at least a 25% risk of permanent
neurological impairment [11–13]. Therapy has been limited to
preventative measures and supportive strategies. Recent experi-
mental and clinical studies clearly show the benefit of induced
hypothermia as a clinically feasible maneuver that improves the
outcome of neonates with HIE [14,15]. It has been shown that a
delay of hypothermia reduces the neuroprotective potential: the
earlier the therapy is initiated, the higher the protective effect [16].
Thus, early biomarkers indicating the duration/severity of hypoxia
and enabling risk stratification immediately after asphyxia might
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severity of hypoxia seem to be of particular importance in cases of
asphyxiated and resuscitated newborns who do not suffer from
conventionally diagnosed and defined HIE as these newborns have
also been described as having an increased risk of low IQ score at
eight years [17]. This makes the search for new biomarkers even
more important towards an early start of neuroprotective therapy.
In addition to early biomarkers for the duration of hypoxia,
there is also a need for in vivo markers of cellular recovery to enable
the monitoring and evaluation of resuscitation strategies. Direct
functional indicators of cellular metabolic response are currently
lacking or of limited use.
The comprehensive quantitative assessment of plasma metab-
olites might bridge this information gap by depicting such
functional information, as metabolite differences in plasma provide
the closest link to cellular metabolism in the whole body and its
response to asphyxia and resuscitation. Thus, the extensive
characterization of the largest possible number of metabolites
from relevant or potentially impacted metabolic pathways is a
promising approach.
The aim of the current study was to evaluate the effects of
asphyxia and resuscitation with different oxygen concentrations on
the plasma metabolites in newborn piglets. We hypothesized that
the comprehensive quantification of plasma metabolites would: 1)
enable the identification of a biochemical marker or marker
combinations that correlate(s) with the duration of hypoxia better
than lactate, pH and base excess; and 2) be a tool to monitor and
describe the effects of the therapeutic intervention on a functional
level andthus provide biochemical evidenceforthecellularintegrity
as well as metabolism recovery due to different resuscitation
protocols. To test these hypotheses, we chose a well-known animal
model of perinatal asphyxia. Hypoxemia of different durations was
induced in newborn piglets before randomization for resuscitation
with 21% or 100% oxygen for 15 min and then 21% oxygen for
45 min or 100% oxygen for 60 min. Quantification of metabolites
was carried out on blood samples taken before and after hypoxia
and after resuscitation. The experimental study design is visualized
in Figure 1.
Results
Cohort Characterization during the Experiment
The summary of the cohort characteristics before hypoxia, after
hypoxia and after reoxygenation is given in Table 1. The
preliminary inspection of the design structure did not reveal
significant differences between the treatment groups (Tukey
adjusted p value greater than 0.1 for any group comparison) with
respect to the clinical parameters (Hb, age, bodyweight, pH, BE,
lactate, glucose and MABP) measured after each piglet underwent
a one-hour stabilization/relaxation procedure. Hypoxia lasted on
average 69624 minutes (n=27) and was not found to be
significantly different between the three groups (F(2,13.7)=1.9,
p=0.18). Hypoxia induced significant changes in the pH, lactate,
BE and MABP to a similar extent in the three groups that
underwent hypoxia (Tukey adjusted p-value,0.001 for any
comparison involving the control group and p.0.2 otherwise).
Effect of Hypoxia and Reoxygenation on Plasma
Metabolites Is Independent of the Mode of
Reoxygenation
The effect of hypoxia on plasma metabolites was assessed
by metabolite concentration changes before and after hypoxia
between asphyxiated animals and control animals. Out of 213
metabolites that could be quantified, 45 analytes and 11 ratios
Figure 1. Experimental study design. After one hour of stabilization, 27 piglets were randomized to hypoxia and reoxygenation (HR). Hypoxemia
(start of asphyxia, SA) was achieved by ventilation with a gas mixture of 8% O2 in N2 until either the mean arterial blood pressure decreased to
20 mmHg or the base excess (BE) reached 220 mM (end of asphyxia, EA). Before the start of resuscitation, the hypoxic piglets were block-
randomized for resuscitation with 21% or 100% oxygen for 15 min and then ventilation with room air for 45 min (Groups 1 (n=8) and 2 (n=8)) or for
receiving 100% oxygen for 60 min (Group 3 (n=11)). Control animals were handled as the other groups without exposure to hypoxia or hyperoxia.
Blood samples for metabolomic analyses were taken at the start of hypoxia (SA), the end of hypoxia (EA) and the end of reoxygenation (ER).
doi:10.1371/journal.pone.0009606.g001
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the corrected p-value distribution due to the effect of asphyxia.
Predominant changes due to asphyxia include metabolites
belonging to acylcarnitines, amino acids, biogenic amines and
members of the energy metabolism pathway, whereas lipids, bile
acids and oxysterols were not disrupted directly after asphyxia.
The investigation of chemical changes associated with the
reoxygenation, independent of the mode of reoxygenation, lead
to similar conclusions where 57 compounds and 16 ratios were
significantly changing at p-values,0.01. Figure 2b provides a
detailed presentation of the effect of asphyxia as well as the
resuscitation on the degree of metabolite changes due to asphyxia
and resuscitation (data are given as mean fold change of
metabolite concentration during asphyxia (blue) and during
reoxygenation (orange); *q,10
22,* *q ,10
24 and *** q,10
26
versus controls at same time points). To illustrate the individual
changes of metabolite levels due to the hypoxia challenge as well as
reoxygenation in each animal, the heat-map in Figure 3 is
provided. In this heat-map, each metabolite (right y- axis) that
changed significantly in each animal (x-axis) is provided. Each
animal is thereby presented twice: first for the metabolite change
due to hypoxia, and secondly for the metabolite change due to
reoxygenation (compared to the controls for the corresponding
time interval). The color reflects the direction of change (blue:
Table 1. Characterization of the study cohort.
21%
100% for 15 min,
21% for 45 min 100% for 60 min Control p values
Weight (g) 1948 (134) 1693 (552) 1951 (132) 1868 (78) 0.20
Age (h) 23.0 (5.7) 20.8 (5.1) 21.1 (4.4) 30.0 (2.9) 0.08
Gender M/F 4/4 3/5 5/6 3/3 0.9
Hb g/100 ml start 8.1 (0.9) 7.5 (1.8) 7.5 (1.4) 7.6 (1.3) 0.74
Hypoxia (min) 57 (13) 86 (33) 61 (13) - 0.06
pH start 7.44 (0.005) 7.48 (0.006) 7.44 (0.005) 7.42 (0.007) 0.34
End hypoxia 6.90 (0.04) 6.91(0.05) 6.95 (0.09) 7.43(0.03) ,0.001
end reoxygenation 7.34 (0.06) 7.34 (0.07) 7.36 (0.09) 7.43(0.03) 0.01
BE mmol/L start 3.3 (3.1) 5.4 (3.7) 5.2 (4.7) 1.9 (3.1) 0.26
End hypoxia 220.2 (2.1) 219.9 (2.1) 218.7 (3.7) 2.64 ,0.001
end reoxygenation 26.1 (2.5) 28.0 (4.1) 23.8 (4.6) 1.5 (1.4) ,0.001
MABP mmHg start 75 (9) 72 (15) 71 (13) 74 (10) 0.84
End hypoxia 42 (16) 43 (16) 41 (16) 84 (12) ,0.001
end reoxygenation 53 (4) 48 (8) 53 (8) 74 (9) ,0.001
SaO2% start 96 (1) 97 (2) 96 (1) 95 (3) 0.53
End hypoxia 29 (3) 30 (5) 30 (5) 96 (2) ,0.001
end reoxygenation 94 (2) 95 (2) 100 (0) 94 (3)
Heart Rate start 189 (30) 176 (54) 194 (56) 150 (31) 0.13
End hypoxia 216 (24) 230 (20) 206 (43) 171 (48) 0.10
end reoxygenation 229 (27) 215 (51) 230 (28) 167 (39) 0.03
pO2 kPa start 11.5 (0.6) 11.8 (1.5) 11.3 (0.9) 10.7 (1.8) 0.60
End hypoxia 4.7 (0.4) 4.4 (0.5) 4.5 (0.7) 11.8 (1.6) ,0.001
end reoxygenation 11.5 (1.3) 11.9 (2.0) 59.8 (9.1) 10.6 (2.0) ,0.001
pCO2 kPa start 5.3 (0.4) 5.2 (0.5) 5.8 (0.5) 5.6 (0.9) 0.14
End hypoxia 8.8 (0.3) 8.7 (0.5) 8.3 (0.8) 5.5 (1.0) ,0.001
end reoxygenation 4.9 (0.4) 4.6 (0.79 5.2 (0.7) 5.3 (0.8) 0.36
Glucose start 6.9 (0.8) 6.6 (1.4) 6.4 (1.8) 7.0 (0.6) 0.78
End hypoxia 10.4 (4.2) 8.0 (3.9) 7.0 (4.5) 6.2 (0.6) 0.09
end reoxygenation 8.8 (2.8) 6.9 (2.7) 6.1 (2.6) 6.1 (0.4) 0.18
Lactate start 2.0 (0.8) 3.2 (2.4) 2.8 (1.0) 2.5 (0.9) 0.38
End hypoxia 13.7 (4.7) 13.6 (4.5) 12.6 (5.4) 1.5 (0.7) ,0.001
end reoxygenation 8.6 (2.2) 10.5 (3.3) 8.9 (2.5)| 1.3 (0.7) ,0.001
Characterization of the study cohort before, directly after asphyxia and after reoxygenation, using classically used parameters in the clinic: The preliminary inspection of the
design structure did not reveal significant differences between the treatment groups (Tukey adjusted p value greater than 0.1 for any group comparison) with respect
to the clinical parameters (Hb, age, bodyweight, pH, BE, lactate and MABP) measured after the piglets underwent a one-hour stabilization/relaxation procedure. Hypoxia
was not found to be significantly different between the three groups (F (2, 13.7) =1.9, p=0.18). Hypoxia induced significant changes in pH, lactate, BE and MABP to a
similar extent in the three groups of animals that underwent hypoxia (Tukey adjusted p value,0.001 for any comparison involving the control group and p.0.2
otherwise, n= 8, 8, 11 and 6 for the 21%, 100% for 15 min, 100% for 60 min and control groups, respectively; italic values show the control group at corresponding time
points).
doi:10.1371/journal.pone.0009606.t001
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PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9606Figure 2. Distribution of the metabolites classes. The distribution of the corrected p value according to the metabolites classes from the two
linear models describing alterations between control and treated animals during asphyxia (left boxplot) and changes in the plasma metabolome
during reoxygenation (right boxplot). The number of significant changes at q-value,0.01 is appearing below each boxplot, alongside with the total
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PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9606Figure 3. Visualization of individual metabolite concentration ratios. The heat-map is a graphical representation of the true metabolite
concentration changes in a two-dimensional, rectangular and colored grid. Metabolites are given on the y axis (i.e., row), animal profiles are given on
the x axis (i.e., columns) and each ‘‘pixel’’ represents a metabolite change (in log basis 2 scale) between two consecutive time points. With regard to
the design, each animal (as labeled by G/g) is thus represented twice: one cell for each change corresponding to the hypoxia (i.e., EA/SA) and to the
resuscitation (i.e., ER/EA) steps. For a more comprehensive visualization, metabolite changes are centered around a common value, and both rows
and columns are reordered so that meaningful characteristics of the data can be uncovered without any a priori knowledge about the experimental
design. First, concentration changes for each metabolite (row) are centered around the average change found in the sham animals (i.e., control
animals labeled by g). Following the left corner diagram, red (resp. blue)-colored cells indicate a higher (resp. a lower) change in concentration than
the average change observed for the control animals. Cells for which changes are greater than 3 (c.a. 2^3=8 fold change) and lower than 23 (c.a. 1/
8) are coded in the darkest red and blue. Column reordering proceeds by placing observations (i.e., EA/SA or ER/EA from one animal) with the most
similar profiles, using hierarchical clustering agglomeration in which the leaves represent individual observations and in which the height of the
nodes reflects the dissimilarity between the two clusters of observation. Animal labels are given at the bottom, whereas a square color-coded
according to its treatment group is at the top of the heat-map. Three clusters, corresponding to the profiles from the asphyxiated animals (left)
followed by the sham animals (center) and profiles associated to resuscitation (right), are clearly observed. However, unsupervised clustering cannot
efficiently group animals according to their reoxygenation protocol (right). Finally, metabolites (i.e., rows) are grouped according to their intensity
patterns, with their partitions displayed on the left side. The upper part of the heat-map comprises metabolites that are increased during asphyxia
and decreased during resuscitation, whereas the lower part regroups compounds with the opposite behavior.
doi:10.1371/journal.pone.0009606.g003
number of metabolites for a given class in brackets. A detailed description of each group of metabolites is given in Table S1. Figure 3b) Concentration
changes of metabolites for treated animals during asphyxia (EA/SA, blue) and during reoxygenation (ER/EA, orange). Levels of significance are as
follows: *, q,10-2, **, q,10-4 and *** q,10-6.
doi:10.1371/journal.pone.0009606.g002
Metabolomic Insights
PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9606decrease, red: increase), while the color intensity reflects the level
of significance. The grouping of animals (x-axis) is a result of an
unsupervised clustering of the animals according to their
metabolite pattern. Three groups (clusters), corresponding to the
profiles from the hypoxic animals (left) followed by the sham
animals (center) and profiles associated to reoxygenation (right),
are clearly observed. Even under standardized conditions, each
individual animal has its individual metabolomic response due to
hypoxia. In the control animals, there were no significant changes
of the metabolites. In the reoxygenated animals, although there is
a clear clustering of the animals, unsupervised clustering did not
efficiently group animals according to their reoxygenation protocol
(right).
Correlation with the Duration of Hypoxia
Figure 4a shows the tracing of lactate levels and its change due
to hypoxia and resuscitation in each animal. In most but not all of
the animals, hypoxia resulted in an immediate increase of lactate
within the first 15 minutes. Thereafter, the lactate levels remained
stable in most of the animals. The correlation of lactate levels with
the duration of hypoxia revealed no correlation, as shown in
Figure 4b (R
2.adj=0.13, p=0.36). Similarly, base excess
(R
2.adj=0.01, p=0.4) and pH (R
2.adj=0.03, p=0.5) also did
not correlate with the duration of hypoxia. In contrast, we
detected the ratios of alanine to branched chained amino acids,
Ala/BCAA (R
2.adj=0.58, q-value,0.001), and of glycine to
BCAA, Gly/BCAA (R
2.adj=0.45, q-value,0.005), which per se
highly correlated with the duration of hypoxia. Figure 4d shows
the results of multivariate modeling of the duration of hypoxia by
mean of partial least square (PLS) including acylcarnitines, amino
acids, intermediates of energy metabolism, biogenic amines and
any ratios involving these compounds. The combination of
different metabolites and metabolite ratios results in a strong
correlation with the duration of hypoxia. Figure 4c highlights the
variables showing the 30 largest VIP (Variable Importance in the
Projection) values that were extracted from the PLS model,
shedding light onto the role played by specific metabolites and
ratios in modeling the length of hypoxia. After reducing the
dataset to metabolites and ratios with VIP values greater than 1,
the predictive power of the PLS model was increased: R
2=0.85,
Q
2=0.65, RMSE=13.9 minutes, p,0.0001 (Figure 4d).
Effect of Resuscitation Protocols on Plasma Metabolites
Figures 5a and 5b illustrate metabolites that are significantly
affected by the different modes of reoxygenation. Four small acids
exhibited dramatic increases during hypoxia (resp. 850%, 266%,
8000% and 587% for lactate, alpha keto-glutarate, succinate and
fumarate, respectively). Reoxygenation led to a decrease of these
metabolites, but whereas lactate levels declined in all three groups to
a similar extent, the Krebs cycle intermediates alpha keto-glutarate,
succinate and fumarate were significantly reduced at different rates
depending onthe resuscitation protocol(Figure 5a), showinga faster
decline in the 21% reoxygenation group. Additional metabolites
showing different responses to reoxygenation included oxysterols
and acylcarnitines (Figure 5b) (data are given as mean fold changes
during reoxygenation + SEM. Levels of significance in Figures 5a–b
are coded as follows: *, q,10
22, **, q,10
23 vs. group 1).
Discussion
In this study, we performed a comprehensive quantitative
characterization of plasma metabolites in newborn piglets before
and after hypoxia as well as after reoxygenation with different
oxygen concentrations. We describe two major findings:
First, hypoxia induced significant changes in plasma metabo-
lites. Interestingly, clinical used parameters like lactate, base deficit
and pH did not correlate with the duration of hypoxia. In contrast,
we identified (to the best of our knowledge) for the first time a set
of markers with good correlation to the duration of hypoxia.
Second, reoxygenation also induced a broad change of plasma
metabolites, with significant differences depending on the resusci-
tation protocol. The pronounced decline of the Krebs cycle
intermediates succinate, fumarate and alpha keto-glutarate indi-
cates an earlier recovery of mitochondrial function when 21% of
oxygen is used for resuscitation compared to 100% oxygen.
Therefore, these findings may have major importance for i) the
diagnosis of asphyxia not only in newborns and ii) the treatment of
asphyxiated newborn infants.
Effect of Asphyxia on Plasma Metabolites
Exposure to severe, prolonged hypoxia revealed changes in
metabolites belonging to acylcarnitines, amino acids, biogenic
amines and members of the energy metabolism pathway. Thereby
we detected decreases of free carnitine (C0) and decadienyl-L-
carnitine (C10:2) and an increase in mainly long chain acyl
carnitines after hypoxia. This is in agreement with other data,
where levels of free and total carnitine were lower and levels of
long chain acyl carnitines were higher in asphyxiated newborn
babies than in controls [18,19]. It was speculated that they may
serve as fuel for cerebral energy metabolism [20]. Our results show
that incomplete fatty acid oxidation during hypoxia leads to an
increase of coenzyme A esters of fatty acids, which are bound to
carnitine forming acylcarnitines and therefore contribute to the
detoxification of the free fatty acids, which have been shown to
have toxic potential. The decrease in carnitine is of concern, as
carnitine is required for a normal mitochondrial function [21,22].
In addition, newborns have an increased risk of cellular injury
related to carnitine deficiency because of the immaturity of the
carnitine biosynthetic pathways [23,24]. L-carnitine can suppress
lipid peroxydation after ischemia reperfusion [25] and can
suppress hydroxyl radical production in the Fenton reaction.
Together with propionyl-L-carnitine (C3), L-carnitine possesses
potent antioxidant activity [26]. The lack of carnitine may thereby
give more oxidative stress. Experimentally, L-carnitine treatment
after HI has been associated with a reduction in neurological
injury [27]. An antiapoptotic role of carnitine has also been
proposed [28,29]. Because L-carnitine possesses minimal toxicity
and has been in extensive use in pediatric clinical settings, it is an
attractive drug for perinatal asphyxia [30]. However, carnitine
supplementation is still controversial. It has been widely discussed
whether supplementation of exogenous carnitine is advisable for
the recovery of reduced intracellular carnitine concentrations
[31,32]. In addition to the acylcarnitine data, the results obtained
in this study go far beyond the current knowledge as the
investigation reveals additional metabolites and metabolite ratios
that describe the status of asphyxia on a cellular level in much
greater detail than acylcarnitines alone. Currently, we cannot
explain every single finding, and at this stage, we can only
speculate about the biochemical pathways involved. This is far
beyond the aim of the study and the possibilities given in one
manuscript. Additional analyses are required, and we share all
findings to open this up to other investigators. However, the
comprehensive analyses of plasma metabolites enabled us to
investigate whether other metabolites, ratios and/or combinations
of metabolites do correlate with the duration of hypoxia and to
compare these findings with the correlations of clinically used
parameters.
Metabolomic Insights
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The analysis of metabolite changes during hypoxia in relation to
the duration of hypoxia revealed components that could explain
and predict the variation in the time of hypoxia. The ratios of Ala/
BCAA and Gly/BCAA alone are highly significant predictors of
the duration of hypoxia. By combining these ratios with other
metabolites, e.g., intermediates of the Krebs cycle (succinate) and
propionyl-L-carnitine (C3), the correlation with the duration of
hypoxia was increased to R
2=0.96. The fact that the Ala/BCAA
and Gly/BCAA ratios are highly correlated with the duration of
hypoxia can be partially explained by the reduction of the
metabolic noise by relating the measured concentrations to
parameters that are not involved in the investigated pathway but
that reflect variations in, e.g., analytical factors and absorption
Figure 4. Correlation of metabolite concentration with the duration of hypoxia. The time-course of plasma lactate levels (in mM) of all
individual animals before, during and after asphyxia in a normalized discrete timescale (animals are sampled at 15/30 minutes intervals during
asphyxia and resuscitation/reoxygenation) (a). Lactate concentration (mM) does not correlate with the duration of hypoxia (in minutes) (b). The fitted
values of the PLS models built on the full set (+) or reduced (*) set of metabolites and ratios of metabolites are plotted against the actual duration of
asphyxia (in minutes) Combinations of metabolites by PLS modeling provided a better representation of the duration of asphyxia (c). n=8–11. The 30
most contributing features are sorted according to the variable importance on the projection (VIP) scores; VIP are given as median and 20/80
quantiles from 30 resampling steps (d).
doi:10.1371/journal.pone.0009606.g004
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correlate with the duration of hypoxia (except for the first 15–30
minutes) can be explained by the fact that these parameters are
impacted by individual enzymatic activities, nutritional status and
compensatory mechanisms. The important roles of succinate and
C3 in the statistical model can be seen as the result of their strong
direct associations with mitochondrial function, thereby mirroring
direct mitochondrial activity. Although we cannot provide an
explanation for all of the metabolites contributing to the
biomarker set, the detailed characterization of the metabolomic
response enables discussion and opens a new field of research.
These data led us to propose a new concept of using several
metabolites to characterize the severity of hypoxia and thus the
risk stratification of tissue injury.
Effect of Different Reoxygenation Protocols
Fumarate, succinate and alpha keto-glutarate are intermediates
of the Krebs cycle (Figure 6) and are strongly increased after
asphyxia, as are lactate and alanine. This increase is the result of
mitochondrial dysfunction and the subsequent disturbance of the
Krebs cycle and accumulation of metabolites involved in upstream
biochemical pathways (Figure 6a). The lack of oxygen as an
electron acceptor in the respiratory chain results in a diminished
production of ATP. Additionally, the NADH+H
+/NAD
+ ratio is
elevated as these metabolites cannot enter the respiratory chain for
energy production and may serve as cofactors for the formation of
lactate.
The reoxygenation by the different resuscitation protocols
resulted in a decrease of these intermediates, with significant
differences between the different groups. Interestingly, reoxygena-
tion with the high oxygen supplies in group 2 and 3 led to a slower
decline of Krebs cycle intermediates, indicating a longer lasting
disturbance of the Krebs cycle and respiratory chain (Figure 6b).
These results are in accordance with other findings of in vitro
studies showing that hyperoxia causes mitochondrial dysfunction
and cell death by an excessive cellular production of reactive
oxygen species (ROS) [34]. Hyperoxia results in an uncoupled
oxidative phosphorylation in the mitochondrial respiration chain
through a change in the expression levels of Cytochrome b, an
important component of Complex III, and ATPase 6, 8, important
components of enzyme complex V [35]. Thus, the present study
provides the first in vivo data showing that hyperoxia causes a
delayed decrease in metabolites that are biochemically directly
linked to mitochondrial function, thereby supporting the in vitro
data.
In addition to the intermediates of energy metabolism, the
lanosterol and oxysterol levels changed depending on the
resuscitation protocol. Lanosterol was significantly increased after
resuscitation with 100% and prolonged hyperoxia (Group 3).
Lanosterol is the common biosynthetic precursor of cholesterol
and is converted to cholesterol at the sarcolem. An increase of
lanosterol level indicates an inefficient cholesterol synthesis.
Cholesterol is an important compound that is incorporated during
brain development, and several studies have shown that deficits in
cholesterol synthesis [36] or transport [37–39] cause neurodegen-
eration and severe neurological symptoms. Furthermore, the
oxysterols 24S-Hydroxycholesterol (24S-OHC) and 25-Hydroxy-
cholesterol (25-OHC) were significantly increased after prolonged
hyperoxia (group 3). 24S-OHC has been used as a biomarker of
brain cholesterol balance and as a marker of CNS neuronal mass
[40]. Its increase has been associated with acute neuronal damage
because it is able to cross the blood-brain barrier (BBB) [41]. Since
24S-OHC has been described as a brain-specific indicator of acute
neuronal damage, this, in addition with the increased levels of
lanosterol, raises concerns about the exposure of 100% oxygen to
asphyxic newborns.
Clinical Importance
The findings in this study have, in our perspective, major
implications for neonatology and neonatal intensive care medi-
cine, as well as for other insults associated with the lack of oxygen
and in adulthood.
With respect to neonatology, this study provides new biomarkers
that might be useful in a clinical setting for early risk stratification
Figure 5. Concentration ratios of metabolites due to resuscitation protocols. An explicit summary of concentration ratios for the set of
metabolites found significant at a q value,0.01 due to resuscitation protocols (n=8–11). Bars correspond to the paired changes during
reoxygenation (to the left–decline; to the right–increase). Bars in: green: resuscitation with 21%O2; blue: 100% O2 for 15 min and 45 min of 21% O2;
and red: prolonged hyperoxia, 100% for 60 minutes. Levels of significance are coded as follows: *, q,10
22, **, q,10
24.
doi:10.1371/journal.pone.0009606.g005
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interventions like hypothermia. Because we did not assess brain
injury per se, we did not detect biomarkers of brain injury per se.
However, thestudyby Odd et al. clearlyshowed cognitive deficitsin
cohorts suffering from asphyxia and requiring resuscitation without
the classical diagnosis of HIE [17]. There seems to be a gap in
diagnosing and evaluating the severity of asphyxia. As we in this
study as well as others in clinical trials have shown [42], the
conventionally used parameters like pH are of limited use and do
not correlate with the neurological outcome. In clinical practice,
caregivers are challenged by newborns with low pH and the limited
knowledge about the interpretation of this. The metabolites
detected in this study that do correlate with the duration of hypoxia
might help in the clinical setting for either introducing therapy at an
early stage or for risk stratification and close surveillance by other
methods like amplitude integrated electroencephalography (aEEG)
[42,43]. Furthermore, the results add new insights for answering the
question of the ideal mode of resuscitation for newborns,
particularly in the context of other recent findings showing that
the use of extra oxygen for newborn resuscitation negatively
influences both morbidity and mortality [2–7] The effect on Krebs
cycle intermediates indicates the earlier recovery of mitochondrial
function when 21% oxygen is used for resuscitation.
The same biomarkers and metabolomic approach may also be
useful in evaluating or predicting damage in other insults, like after
cardiac arrest, traumatic brain injury or conditions of low
oxygenation associated with low cardiac output in both infancy
and adulthood [20] (LeWcen, Daniel et al: Serum Metabolomic
Biomarkers in Hypothermic and Normothermic Models of
Hemorrhagic Shock Associated with Increased Mortality, 5
th
International Conference of the Metabolomics Society, unpub-
lished data).
Limitations of the Study
As highlighted above, we could not correlate our findings with
other technologies like MRI for indicating the severity of brain
damage, as the tissue collection was performed for other purposes,
e.g., the analyses of neuroprostanes at early timepoints. The
resuscitation with 100% for 15 min resulted in increased levels of
neuroprostanes, known markers of cerebral injury, in the same
animals (data not shown).
Furthermore, this study was performed in a neonatal, not
perinatal, model of hypoxia-reoxygenation. However, newborn
pigs have a structure and size equivalent to newborn infants as well
as have similar immunological and metabolic functions [44–46].
Summary and Conclusion
We identified markers and marker combinations that enable
better risk stratifications after asphyxia as well as that indicate
cellular recovery better than the conventionally used biochemical
parameters (pH, BE and lactate). In addition, we provided in vivo
data showing that resuscitation with hyperoxia delays cellular
recovery. Because metabolites are largely species-independent, our
findings offer promising features paving the way to alternative and
more detailed diagnostic tools for asphyxia and resuscitation.
These biomarkers have to be validated in human trials.
Materials and Methods
Approval
The National Animal Research Authority, (NARA), approved
the experimental protocol. The animals were cared for and
handled in accordance with the European Guidelines for Use of
Experimental Animals by certified FELASA fellows (Federation of
European Laboratory Animals Science Association).
Figure 6. Visualizations into biochemical pathways. Summary and visualizations into biochemical pathways: a) Effect of asphyxia on Krebs cycle
intermediates; Fumarate, succinate and a-ketoglutarate are strongly increased after asphyxia, as well as lactate and alanine. These increases can be
seen as the result of mitochondrial dysfunction and the subsequent disturbance of the Krebs cycle, since the Krebs cycle and mitochondrial function
is coupled. b) Effect of different resuscitation protocols on these intermediates. Reoxygenation with 100% oxygen for either duration (g2/3) resulted in a
significant delay in the decrease in fumarate, succinate and a-ketoglutarate compared to normoxic resuscitation (g1). The significantly lower levels of
these Krebs cycle intermediates in the 21% FiO2 resuscitation group indicates better mitochondrial recovery.
doi:10.1371/journal.pone.0009606.g006
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A total of 33 newborn Noroc (LyxLD) pigs were included in the
study, with inclusion criteria of 12–36 h, Hb.5 g/dL and good
general condition. Twenty-seven of these went through the
experimental procedures, and a reference group consisting of six
newborn pigs went through the same experimental set-up (were
anesthetized, sham operated and ventilated) but were not
subjected to hypoxia and reoxygenation (Figure 1).
Anesthesia was induced by giving sevofluran 5% (Sevorane,
Abbott); an ear vein was cannulated, and the piglets were given
pentobarbital sodium at 15 mg kg
21 and fentanyl at 50 mgk g
21
i n t r a v e n o u s l ya sab o l u si n j e c t i o n . The piglets were orally intubated
and then placed in the supine position and washed for sterile
procedures. Anesthesia was maintained by continuous infusion of
fentanyl (50 mgk g
21 h
21) and midazolam (0.25 mg kg
21 h
21)i n
mixtures, giving 1 mL kg
21 h
21 for each drug applied by IVAC
P2000 infusion pump. When necessary, a bolus of fentanyl
(10 mgk g
21),midazolam(1 mg kg
21)or pentobarbital(2.5 mg kg
21)
was added (need for medication being defined as shivering, trigging
on the respirator, increased tone assessed by passive movements of the
limbs, increase in blood pressure and/or pulse). A continuous IV
infusion (Salidex: saline 0.3% and glucose 3.5%, 10 mL kg
21 h
21)
was given until hypoxia and from 15 min after the start of
resuscitation and throughout the experiment. The piglets were
ventilated with a pressure-controlled ventilator (Babylog 8000+;
Dra ¨gerwerk, Lu ¨beck, Germany). Normoventilation (arterial carbon
dioxide tension (PaCO2) 4.5–5.5 kPa), and a tidal volume of 6–
8m Lk g
21 were achieved by adjusting the peak inspiratory pressure
or ventilatory rate. The ventilatory rate was 15–40 respirations/min.
The inspiratory time of 0.4 s and the positive end-expiratory pressure
of 4.5 cm H2O were kept constant throughout the experiment. The
inspired fraction of O2 and the end-tidal CO2 were continuously
monitored(DatexNormocapOxy;Datex,Helsinki,Finland).Theleft
femoral artery was cannulated with polyethylene catheters (Porex PE-
50, inner diameter 0.58 mm; Porex Ltd Hythe, Kent, UK). The
mean arterial blood pressure (MABP) was measured continuously in
the left femoral artery using BioPac systems MP150-CE. Rectal
temperaturewas maintained between 38.5 and 39.5uC with a heating
blanket and a radiant heating lamp. One hour of stabilization was
allowed after surgery. At the end of the experiment, the piglets were
given an overdose of 150 mg kg
21 pentobarbital intravenously.
Experimental Protocol
Hypoxemia was achieved by ventilation with a gas mixture of
8% O2 in N2 until either the mean arterial blood pressure
decreased to 20 mmHg or the base excess (BE) reached 220 mM.
CO2 was added during hypoxemia, aiming at a PaCO2 of 8.0–
9.5 kPa to imitate perinatal asphyxia. Before the start of
resuscitation, the hypoxic piglets were block-randomized for
resuscitation with 21% or 100% oxygen for 15 min and then
ventilation with room air for 45 min (Groups 1 (n=8) and 2
(n=8)) or for receiving 100% oxygen for 60 min (Group 3
(n=11)). After initiating the reoxygenation, the piglets were kept
normocapnic (PaCO2 4.5–5.5 kPa). Throughout the whole
experiment, there was a continuous surveillance of blood pressure,
saturation, pulse, temperature and blood gas measurements.
Hemoglobin was measured on a HemoCue Hb 201+ (HemoCue
AB, Angelholm, Sweden) at baseline and at the end of the
experiment. Temperature-corrected arterial acid/base status and
glucose were regularly measured throughout the experiment on a
Blood Gas Analyzer 860 (Ciba Corning Diagnostics, Midfield,
Mass., USA). Plasma samples for metabolomic analyses were
drawn before initiating the hypoxia, at the end of hypoxia and
60 min after initiating reoxygenation and were handled according
to standard operating procedures provided by Biocrates Life
Sciences AG and then stored at minus 70uC until subsequent
analysis. All blood samples obtained from the femoral artery
catheter were replaced by normal saline 1.5 x the volume drawn.
One hour after the end of hypoxia, the animals were given an
overdose of pentobarbital (150 mg kg
21 iv). The study staff and
the laboratory personnel were blinded to the percentage of oxygen
administered by resuscitation.
Analyses
General analyses. Sample preparation and metabolomic
analyses were performed at Biocrates life sciences AG, Innsbruck,
Austria. We used a multi-parametric, highly robust, sensitive and
high-throughput targeted metabolomic platform consisting of flow
injection analysis (FIA)-MS/MS and LC-MS/MS methods for the
simultaneous quantification of a broad range of endogenous
intermediates, namely acylcarnitines, sphingomyelins, hexoses,
glycerophospholipids, amino acids, biogenic amines, bile acids,
oxysterols and small organic acids, in plasma. A detailed list of all
analyzed metabolites is provided in Table S1. All procedures
(sample handling, analytics) were performed by co-workers
blinded to the experimental groups.
Acylcarnitines, sphingomyelins, hexoses, glycerophos-
pholipids (FIA-MS/MS). To determine the concentration of
acylcarnitines, sphingomyelins and glycerophospholipids in plasma,
the AbsoluteIDQ kit p150 (Biocrates Life Sciences AG, Innsbruck,
Austria) was prepared as described in the manufacturer’s protocol.
In brief, 10 mL of plasma was added to the center of the filter on the
upper 96-well kit plate and was dried using a nitrogen evaporator
(VLM Laboratories, Bielefeld, Germany). Subsequently, 20 mLo fa
5% solution of phenyl-isothiocyanate was added for derivatization.
After incubation, the filter spots were dried again using an
evaporator. The metabolites were extracted using 300 mLo fa
5 mM ammonium acetate solution in methanol. The extracts were
obtained by centrifugation into the lower 96-deep well plate,
followed by a dilution step with 600 mL of kit MS running solvent.
Mass spectrometric analysis was performed on an API4000 QtrapH
tandem mass spectrometry instrument (Applied Biosystems/MDS
Analytical Technologies, Foster City, CA)equipped with an electro-
spray ionization (ESI)-source, using the analysis acquisition method
as provided in the AbsoluteIDQ kit. The standard FIA-MS/MS
method was applied for all measurements with two subsequent 20-
mL injections (one for positive and one for negative mode analysis).
Multiple reaction monitoring (MRM) detection was used for
quantification, applying the spectra parsing algorithm integrated
into the MetIQ software (Biocrates Life Sciences AG, Innsbruck,
Austria). The concentrations for 148 metabolites (all analytes were
determined with the metabolomics kit except for the amino acids,
which were determined by a different method) obtained by internal
calibration were exported for comprehensive statistical analysis.
Amino acids, biogenic amines (LC-MS/MS). Amino acids
and biogenic amines were quantitatively analyzed by reversed
phase LC-MS/MS to obtain the chromatographic separation of
isobaric (same MRM ion pairs) metabolites for individual
quantification performed by external calibration and by use of
internal standards. A 10 mL sample volume is required for the
analysis using the following sample preparation procedure.
Samples were added on filter spots placed in a 96- solvinert well
plate (internal standards were placed and dried down under
nitrogen before), fixed above a 96 deep well plate (capture plate).
20 mL of 5% phenyl-isothiocyanate derivatization reagent was
added. The derivative samples were extracted after incubation by
aqueous methanol into the capture plate. Sample extracts were
analyzed by LC-ESI-MS/MS in positive MRM detection mode
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(Applied Biosystems/MDS Analytical Technologies, Foster City,
CA). The analyzed individual metabolite concentrations (Analyst
1.4.2 software, Applied Biosystems, Foster City, CA) were
exported for comprehensive statistical analysis.
Bile acids (LC-MS/MS). A highly selective reversed phase
LC-MS/MS analysis method in negative MRM detection mode
was applied to determine the concentration of bile acids in plasma
samples. Samples were extracted via dried filter spot technique in a
96-well plate format, which is well suitable for high-throughput
analysis. For highly accurate quantification, internal standards and
external calibration were applied. In brief, internal standards and
a2 0mL sample volume placed onto the filter spots were extracted
and simultaneously protein precipitated with aqueous methanol.
These sample extracts were measured by LC-ESI-MS/MS with an
API4000 QtrapH tandem mass spectrometry instrument (Applied
Biosystems/MDS Analytical Technologies, Foster City, CA). Data
of bile acids were quantified with Analyst 1.4.2 software (Applied
Biosystems, Foster City, CA,) and finally exported for
comprehensive statistical analysis.
Oxysterols (LC-MS/MS). Oxysterols were quantitatively
analyzed by reversed phase LC-ESI-MS/MS to realize liquid
chromatographic separation and thus individual quantification of
isobaric oxysterols. The most selective detection was performed in
positive MRM detection mode using a 4000 QtrapH tandem mass
spectrometry instrument (Applied Biosystems/MDS Analytical
Technologies, Foster City, CA). Data were quantified with Analyst
1.4.2 software (Applied Biosystems, Foster City, CA). Ratios of
external to internal standards were applied for quantification by
means of external 6-point calibration. A sample volume of 20 mL
(plasma) was necessary for the analysis. The sample preparation
included: I) protein precipitation by placing a 20 mL sample
volume on the filter spot, and precipitation by 200 mL Naı ¨ve; II)
hydrolysis by 100 mL of 0.35 M KOH in 95% ethanol for 2 hrs;
III) a washing step (36200 mLH 2O) to remove hydrolysis reagent;
and, finally, IV) extraction by means of 100 mL aqueous methanol.
The 20 mL sample extracts were analyzed by the developed LC-
ESI-MS/MS method.
Energy metabolism (organic acids) (LC-MS/MS). For
the quantitative analysis of energy metabolism intermediates
(glycolysis, citrate cycle, pentose phosphate pathway, urea cycle),
a hydrophilic interaction liquid chromatography (HILIC)-ESI-
MS/MS method in a highly selective negative MRM detection
mode was used. The MRM detection was performed using an
API4000 QTrapH tandem mass spectrometry instrument (Applied
Biosystems/MDS Analytical Technologies, Foster City, CA). A
20 mL sample volume (plasma) was protein-precipitated and
simultaneously extracted with aqueous methanol in a 96-well
plate format. Internal standards (ratio external to internal
standard) and external calibration were used for highly accurate
quantification. Data were quantified with Analyst 1.4.2 software
(Applied Biosystems, Foster City, CA) and finally exported for
statistical analysis.
Statistics
All statistical calculations were performed using the statistics
software R. Analytes that were detected in at least 15% of the
samples were selected for further analyses, resulting in a list of 213
compounds/metabolites along with 28 known compound/metab-
olite sums and ratios (given in Table S1). Analysis of variance and
covariance followed up with Tukey’s ‘Honest Significant Differ-
ence’ were used to assess potential bias in the experimental design
and changes associated with clinical parameters. For metabolite
measurement, the gls function in the package nlme was used to
compute the linear models, specifying within-treatment group
heteroscedasticity structure and default parameters otherwise.
Metabolite significance levels are presented in the form of q values
after adjustment by the method described in Benjamini and
Hochberg [47] With the exception of fold change (FC)
determination, all statistical analyses were performed on pre-
processed, log-transformed data. Fold changes were computed
from the median ratio of original concentrations between two time
points and are presented as changes compared to the control
group (positive values) or to the treated group (negative values).
Due to a combination of the metabolic pathway dynamism,
complex sample molecular interactions and overall efficiency of
the analytical protocol, the replacement of missing data by means
of a multivariate algorithm is preferred to a naive imputation by a
pre-specified value like, for instance, zero. For the multivariate
analysis only, the missing metabolite concentrations were replaced
by a linear combination of the six most correlated analytes
according to Kim et al. [48] with the method available in the R
package pcaMethods.
Heat-maps consist of explicit representations of concentration
ratios between two time points, where metabolites (row) and
samples (columns) are reordered in an unsupervised fashion.
Column-wise, samples were reordered following complete hierar-
chical cluster agglomeration, and, row-wise, metabolites were
clustered using k means, where k is set to 5. Concentration ratios
are log10-transformed and color-coded following the left corner
diagram: red (resp. blue)-colored cells indicate higher (resp. lower)
concentrations in the sample from the second time point.
Partial Least Square (PLS) regression [49] was carried out with
the R package pls. Data were mean centered and scaled to unit
variance, and the optimal number of components was determined
by leaving one out validation. The PLS model’s predictive abilities
are assessed using 10-fold cross-validation, where 90% of the
samples are used to build the regression model and the remaining
10% are employed to calculate the predictive errors [50]. PLS
models are reported [49]in term of the coefficients of determina-
tion calculated from the fitted values on the overall dataset (R
2)
and from the predicted values (Q
2), in addition to the root mean
square of the predicted error (RMSE). The significance of the
findings are further assessed by subjecting the previous procedure
to permutation testing (n =5000). The resulting empirical p value
corresponds to the proportion of models with higher RMSE than
the PLS model built on the true data. Variable importance values
in the projection (VIP) are computed according to [51]. To
evaluate the stability of the variable importance score under
resampling, VIP values are calculated at each cross validation step
and are presented as the median and the 10% and 90% quantiles.
Supporting Information
Table S1 List of analyzed metabolites.
Found at: doi:10.1371/journal.pone.0009606.s001 (0.07 MB
PDF)
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